Entering text into the input field will update the search result below

Arcturus Therapeutics Q1 2023 Earnings Preview

May 08, 2023 5:35 PM ETArcturus Therapeutics Holdings Inc. (ARCT)By: Anuron Mitra, SA News Editor
  • Arcturus Therapeutics (NASDAQ:ARCT) is scheduled to announce Q1 earnings results on Tuesday, May 9th, after market close.
  • The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $49.46M (vs. $5.24M last year).
  • Over the last 3 months, EPS estimates have seen 4 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 3 downward.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.